Skip to content

Can 'self-confidence workshops' for depression help the implementation of the NICE Guidelines?

Can 'self-confidence workshops' for depression help the implementation of the NICE Guidelines: a randomised controlled trial with repeated measures of a clinical and health economic evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26634837
Enrollment
320
Registered
2010-10-06
Start date
2010-04-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders Depressive episode

Interventions

One-day workshop utilising material from Melanie Fennel's 'Overcoming Low Self-Esteem'. The aim is to help participants understand problems of low self-esteem and to teach different techniques to help

Sponsors

King's College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Depressed people, classified as only those with a Beck Depression Inventory (BDI) score of 14 and above 2. Aged 16 years or over, either sex

Exclusion criteria

Exclusion criteria: 1. Aged less than 16 years 2. Attention problems or organic brain syndrome

Design outcomes

Primary

MeasureTime frame
1. Client Service Receipt Inventory (CSRI): a specially designed short self-report version will be developed and used to assess service use and lost employment 2. Beck Depression Inventory (BDI) for assessment of severity of depression. 4-point Likert scale to measure the extent to which the person is experiencing symptoms of depression. Both measures completed at baseline and 3-month follow-up.

Secondary

MeasureTime frame
1. GAD-7 measure to assess how much the person has been bothered by various symptoms of anxiety on a 4-point Likert scale (0 not at all, 3 nearly every day) 2. Rosenberg Self-Esteem Scale to assess feelings about self on a 4-point Likert scale (0 strongly disagree, 3 strongly agree) 3. The EQ-5D measure of health outcome to enable health-related quality of life and quality-adjusted life-years to be calculated. Participants indicate how they are coping in terms of mobility, self-care, anxiety/depression, pain and completion of usual activities. Also uses a visual analogue scale for indicating health state (0 worst imaginable health state, 100 best imaginable health state). All measures completed at baseline and 3-month follow-up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026